Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Microbiology and Immunology
Published in: Medical Microbiology and Immunology 4/2009

01-11-2009 | Case Report

Ross River virus infection in a traveller returning from northern Australia

Authors: Dennis Tappe, Jonas Schmidt-Chanasit, Angelika Ries, Uwe Ziegler, Andreas Müller, August Stich

Published in: Medical Microbiology and Immunology | Issue 4/2009

Login to get access

Abstract

Ross River virus is an arthropod-borne alphavirus (family Togaviridae) causing epidemic polyarthritis in the Australia-Pacific region. The infection causes substantial morbidity due to long-lasting arthralgia. Despite being the most common arboviral infection in Australia, reports in travellers are scarce. Here, we describe the disease in a German traveller who was not aware of the prevalence of this infection in his holiday destination, the Northern Territory and Queensland, Australia. The patient had neither fever nor rash, but presented with chills, watery diarrhoea and severe, prolonged arthritis.
Literature
1.
Jacups SP, Whelan PI, Currie BJ (2008) Ross River virus and Barmah Forest virus infections: a review of history, ecology, and predictive models, with implications for tropical northern Australia. Vector Borne Zoonotic Dis 8:283–297CrossRefPubMed
2.
Vene S, Lundkvist A (1999) Increased travelling-increased risk of imported viruses. A review of the diagnostic capacity of the Swedish institute for infectious disease control. Swedish. Lakartidningen 96:2838–2841PubMed
3.
Pröll S, Dobler G, Pfeffer M, Jelinek T (1999) Persistent arthralgias in Ross-River-Virus disease after travel to the South Pacific. German. Dtsch Med Wochenschr 124:759–762CrossRefPubMed
4.
Visser LG, Groen J (2003) Arthralgia and rash from Australia caused by Ross river virus. Dutch Ned Tijdschr Geneeskd 147:254–257
5.
Harley D, Sleigh A, Ritchie S (2001) Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev 14:909–932CrossRefPubMed
6.
Doherty RL, Gorman BM, Whitehead RH, Carley JG (1964) Studies of epidemic polyarthritis: the significance of three group a arboviruses isolated from mosquitoes in Queensland. Australas Ann Med 13:322–327PubMed
7.
Williams CR, Fricker SR, Kokkinn MJ (2009) Environmental and entomological factors determining Ross River virus activity in the River Murray Valley of South Australia. Aust N Z J Public Health 33:284–288CrossRefPubMed
8.
Rulli NE, Suhrbier A, Hueston L, Heise MT et al (2005) Ross River virus: molecular and cellular aspects of disease pathogenesis. Pharmacol Ther 107:329–342CrossRefPubMed
9.
Ryan PA, Alsemgeest D, Gatton ML, Kay BH (2006) Ross River virus disease clusters and spatial relationship with mosquito biting exposure in Redland Shire, southern Queensland, Australia. J Med Entomol 43:1042–1059CrossRefPubMed
10.
Carver S, Spafford H, Storey A, Weinstein P (2009) Dryland salinity and the ecology of Ross River virus: the ecological underpinnings of the potential for transmission. Vector Borne Zoonotic Dis Mar 27, Epub ahead of print
11.
Tong S, Dale P, Nicholls N, Mackenzie JS, Wolff R, McMichael AJ (2008) Climate variability, social and environmental factors, and ross river virus transmission: research development and future research needs. Environ Health Perspect 116:1591–1597PubMedCrossRef
12.
Pollard H, Benz G (1998) Manifestations of the Ross River and Barmah Forest arboviruses: a clinical challenge for chiropractors. Australas Chiropr Osteopathy 7:116–119PubMed
13.
Condon RJ, Rouse IL (1995) Acute symptoms and sequelae of Ross River virus infection in South-Western Australia: a follow-up study. Clin Diagn Virol 3:273–284CrossRefPubMed
14.
Flexman JP, Smith DW, Mackenzie JS, Fraser JR et al (1998) A comparison of the diseases caused by Ross River virus and Barmah Forest virus. Med J Aust 169:159–163PubMed
15.
Panning M, Wichmann D, Grywna K, Annan A et al (2009) No evidence of chikungunya virus and antibodies shortly before the outbreak on Sri Lanka. Med Microbiol Immunol 198:103–106CrossRefPubMed
16.
Kowalzik S, Xuan NV, Weissbrich B, Scheiner B et al (2008) Characterisation of a chikungunya virus from a German patient returning from Mauritius and development of a serological test. Med Microbiol Immunol 197:381–386CrossRefPubMed
17.
Kistner O, Barrett N, Brühmann A, Reiter M et al (2007) The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans. Vaccine 25:4845–4852CrossRefPubMed
Metadata
Title
Ross River virus infection in a traveller returning from northern Australia
Authors
Dennis Tappe
Jonas Schmidt-Chanasit
Angelika Ries
Uwe Ziegler
Andreas Müller
August Stich
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 4/2009
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-009-0122-9

Other articles of this Issue 4/2009

Medical Microbiology and Immunology 4/2009 Go to the issue

Editorial

Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed?

Original Investigation

Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles

Original Investigation

Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method

Review

Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host

Original Investigation

Manganese-induced changes of the biochemical characteristics of the recombinant wild-type and mutant PrPs

Original Investigation

Multicentre evaluation of the Elecsys® hepatitis B surface antigen II assay for detection of HBsAg in comparison with other commercially available assays
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits